Titus Kretzschmar

1.0k total citations
20 papers, 826 citations indexed

About

Titus Kretzschmar is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Titus Kretzschmar has authored 20 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Titus Kretzschmar's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Protein purification and stability (6 papers) and Complement system in diseases (5 papers). Titus Kretzschmar is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Protein purification and stability (6 papers) and Complement system in diseases (5 papers). Titus Kretzschmar collaborates with scholars based in Germany, Switzerland and United States. Titus Kretzschmar's co-authors include T von Rüden, Martin Geiser, Wilfried Bautsch, Andreas Klos, Jörg Köhl, Silke U. Reiffert, Robert Rauchenberger, D Bitter-Suermann, Michael Tesar and Achim Knappik and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Biochemistry.

In The Last Decade

Titus Kretzschmar

20 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Titus Kretzschmar Germany 15 519 456 302 86 68 20 826
John M. Jarvis United Kingdom 15 616 1.2× 453 1.0× 631 2.1× 45 0.5× 26 0.4× 17 1.1k
Peter Verheesen Netherlands 13 357 0.7× 296 0.6× 155 0.5× 105 1.2× 20 0.3× 21 794
Bodo Brocks Germany 13 499 1.0× 428 0.9× 156 0.5× 23 0.3× 45 0.7× 21 828
Randy Robinson United States 13 767 1.5× 773 1.7× 479 1.6× 69 0.8× 98 1.4× 31 1.5k
Jan‐Willem Arends Netherlands 8 571 1.1× 523 1.1× 146 0.5× 18 0.2× 99 1.5× 9 834
Christine C. Malone United States 16 333 0.6× 188 0.4× 276 0.9× 78 0.9× 10 0.1× 42 744
Gabriella Huerta United States 5 320 0.6× 325 0.7× 410 1.4× 26 0.3× 26 0.4× 5 736
R A Reisfeld United States 18 805 1.6× 629 1.4× 480 1.6× 38 0.4× 21 0.3× 28 1.3k
Mark C. Glassy United States 19 609 1.2× 549 1.2× 494 1.6× 49 0.6× 11 0.2× 74 1.1k
Jason M. Link United States 15 377 0.7× 268 0.6× 353 1.2× 23 0.3× 30 0.4× 32 791

Countries citing papers authored by Titus Kretzschmar

Since Specialization
Citations

This map shows the geographic impact of Titus Kretzschmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Titus Kretzschmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Titus Kretzschmar more than expected).

Fields of papers citing papers by Titus Kretzschmar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Titus Kretzschmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Titus Kretzschmar. The network helps show where Titus Kretzschmar may publish in the future.

Co-authorship network of co-authors of Titus Kretzschmar

This figure shows the co-authorship network connecting the top 25 collaborators of Titus Kretzschmar. A scholar is included among the top collaborators of Titus Kretzschmar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Titus Kretzschmar. Titus Kretzschmar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szabó, Emese, et al.. (2018). Antitumor Activity of DLX1008, an Anti-VEGFA Antibody Fragment with Low Picomolar Affinity, in Human Glioma Models. Journal of Pharmacology and Experimental Therapeutics. 365(2). 422–429. 15 indexed citations
2.
Faust, Nicole, et al.. (2007). High-throughput transfection and engineering of primary cells and cultured cell lines – an invaluable tool for research as well as drug development. Expert Opinion on Drug Discovery. 2(11). 1453–1465. 2 indexed citations
3.
Frisch, Christian, Bodo Brocks, Ralf Ostendorp, et al.. (2003). From EST to IHC: human antibody pipeline for target research. Journal of Immunological Methods. 275(1-2). 203–212. 15 indexed citations
4.
Rauchenberger, Robert, Eric Borges, Eran Rom, et al.. (2003). Human Combinatorial Fab Library Yielding Specific and Functional Antibodies against the Human Fibroblast Growth Factor Receptor 3. Journal of Biological Chemistry. 278(40). 38194–38205. 91 indexed citations
5.
Kretzschmar, Titus & T von Rüden. (2002). Antibody discovery: phage display. Current Opinion in Biotechnology. 13(6). 598–602. 98 indexed citations
6.
Nagy, Zoltan A., Bernd Hubner, Robert Rauchenberger, et al.. (2002). Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells. Nature Medicine. 8(8). 801–807. 122 indexed citations
7.
Krebs, Barbara, Robert Rauchenberger, Silke U. Reiffert, et al.. (2001). High-throughput generation and engineering of recombinant human antibodies. Journal of Immunological Methods. 254(1-2). 67–84. 130 indexed citations
8.
9.
Kretzschmar, Titus, et al.. (1996). High-level expression in insect cells and purification of secreted monomeric single-chain Fv antibodies. Journal of Immunological Methods. 195(1-2). 93–101. 36 indexed citations
10.
Kretzschmar, Titus & Martin Geiser. (1995). Evaluation of antibodies fused to minor coat protein III and major coat protein VIII of bacteriophage M 13. Gene. 155(1). 61–65. 47 indexed citations
11.
Kretzschmar, Titus, Catherine Zimmermann, & Martin Geiser. (1995). Selection Procedures for Nonmatured Phage Antibodies: A Quantitative Comparison and Optimization Strategies. Analytical Biochemistry. 224(1). 413–419. 28 indexed citations
12.
Kretzschmar, Titus, Andreas Jeromin, Wilfried Bautsch, et al.. (1993). Chronic myelogenous leukemia‐derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a. European Journal of Immunology. 23(2). 558–561. 58 indexed citations
13.
Ambrosius, Dorothee, Joachim Grötzinger, Titus Kretzschmar, et al.. (1993). Cyclic disulfide analogues of the complement component C3a Synthesis and conformational investigations. International journal of peptide & protein research. 41(4). 362–375. 15 indexed citations
14.
15.
Kola, Axel, Andreas Klos, W. Bautsch, Titus Kretzschmar, & Jörg Köhl. (1992). Functional activities of synthetic anaphylatoxic peptides in widely used biological assays. Clinical & Experimental Immunology. 88(2). 368–372. 9 indexed citations
16.
Kretzschmar, Titus, Martina Pohl, Wilfried Bautsch, et al.. (1992). Synthetic peptides as antagonists of the anaphylatoxin C3a. European Journal of Biochemistry. 210(1). 185–191. 19 indexed citations
17.
Bautsch, Wilfried, et al.. (1992). Human C5a Anaphylatoxin: Gene Cloning and Expression in Escherichia coli. Immunobiology. 185(1). 41–52. 20 indexed citations
18.
Bautsch, W., Titus Kretzschmar, Axel Kola, et al.. (1992). A recombinant hybrid anaphylatoxin with dual C3a/C5a activity. Biochemical Journal. 288(1). 261–266. 11 indexed citations
19.
Kretzschmar, Titus, et al.. (1991). Characterization of the C5a Receptor on Guinea Pig Platelets. Immunobiology. 183(5). 418–432. 16 indexed citations
20.
Jeromin, Andreas, Gerhard Rechkemmer, Titus Kretzschmar, et al.. (1991). Functional expression of a human C5a receptor clone in Xenopus oocytes requires additional RNA. FEBS Letters. 291(2). 208–210. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John M. Jarvis Breakdown of academic impact, for papers by Peter Verheesen Breakdown of academic impact, for papers by Bodo Brocks Breakdown of academic impact, for papers by Randy Robinson Breakdown of academic impact, for papers by Jan‐Willem Arends Breakdown of academic impact, for papers by Christine C. Malone Breakdown of academic impact, for papers by Gabriella Huerta Breakdown of academic impact, for papers by R A Reisfeld Breakdown of academic impact, for papers by Mark C. Glassy Breakdown of academic impact, for papers by Jason M. Link
Rankless by CCL
2026